Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vaccines

Set Alert for Vaccines

Merck introduces combination poultry vaccine to US

Merck Animal Health has launched its Innovax ND-ILT vaccine for poultry in the US. 

Merck MSD Animal Health Vaccines

Mazen wants investment to fuel advanced PEDV vaccine studies

US biotechnology firm Mazen Animal Health is ready to scale up its R&D for low-cost oral recombinant vaccines.

Investments R&D

AgResults to launch FMD vaccine project for East Africa

AgResults is going to follow up the success of its ongoing brucellosis vaccine development competition with a project focused on developing a vaccine for foot-and-mouth disease (FMD).

Middle East and Africa R&D

Argentine firm secures domestic authorization for FMD vaccine

Authorities in Argentina have approved an anti-viral foot-and-mouth disease (FMD) vaccine developed by local company CDV Laboratory

Argentina Product Approvals

VLPbio lines up partner for PRRS immunotherapeutic vaccine

Spanish biotechnology company VLPbio has secured a license option deal with an unnamed partner for its vaccine candidate against porcine reproductive and respiratory syndrome (PRRS).

Deals R&D

Malcisbo seeks funding to develop carbohydrate-based vaccines for livestock

Swiss start-up Malcisbo is looking for investment to further develop its glyco-conjugate poultry and swine vaccines.

Investments R&D

Boehringer gains positive opinion for porcine parvovirus vaccine

Boehringer Ingelheim's ReproCyc ParvoFLEX vaccine has moved one step closer to European approval after gaining a positive opinion ruling from authorities. 

Boehringer Ingelheim Animal Health Product Approvals

Algenex supports development of recombinant biologics with €4m funding round

Spanish biotechnology firm Algenex has progressed to its next stage of development after securing approximately €4 million ($4.5 million) in investment.

Vaccines Investments

Hipra launches edema vaccine for pigs in Canada

Laboratorios Hipra Canada has launched Vepured, which is a vaccine to tackle edema disease in its clinical and subclinical form in pigs.

Hipra Vaccines

Ceva to introduce new combination vaccine to US poultry market

Ceva Santé Animale is bringing Ultifend IBD ND to the US poultry market in the coming weeks.

Ceva Sante Animale Vaccines

Syva secures its first EU centralized approval with bluetongue vaccine

Spanish firm Laboratorios Syva has secured European approval for Syvazul BTV – an inactivated multi-strain vaccine against bluetongue disease caused by serotypes 1, 4 and 8.

Europe Vaccines

Merck upgrades Delaware manufacturing space

Merck Animal Health is pouring investment into its manufacturing and warehousing site in Millsboro, Delaware.

Merck MSD Animal Health Operations
See All
Advertisement
UsernamePublicRestriction

Register